These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibition. Demers C, Henderson P, Blajchman MA, Wells MJ, Mitchell L, Johnston M, Ofosu FA, Fernandez-Rachubinski F, Andrew M, Hirsh J. Thromb Haemost; 1993 Mar 01; 69(3):231-5. PubMed ID: 8470046 [Abstract] [Full Text] [Related]
7. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence. Bohner J, von Pape KW, Blaurock M. Thromb Haemost; 1994 Mar 01; 71(3):280-3. PubMed ID: 8029789 [Abstract] [Full Text] [Related]
10. An investigation of the functional role of the carboxylic groups of heparin. Affinity for antithrombin III and anti-Xa activity of selectively carboxyl esterified heparin. Mardiguian J, Trillou M. Semin Thromb Hemost; 1985 Jan 01; 11(1):34-6. PubMed ID: 3975640 [No Abstract] [Full Text] [Related]
16. In vivo age dependency of unfractionated heparin in infants and children. Newall F, Ignjatovic V, Summerhayes R, Gan A, Butt W, Johnston L, Monagle P. Thromb Res; 2009 Mar 01; 123(5):710-4. PubMed ID: 18829072 [Abstract] [Full Text] [Related]
17. Comparison of the non-specific binding of unfractionated heparin and low molecular weight heparin (Enoxaparin) to plasma proteins. Young E, Cosmi B, Weitz J, Hirsh J. Thromb Haemost; 1993 Oct 18; 70(4):625-30. PubMed ID: 8115988 [Abstract] [Full Text] [Related]